| UK AGM, EGM Calendar |
| Wednesday, June 10 |
| Hurricane Energy |
| InternetQ |
| Patagonia Gold |
| CDialogues |
| Falkland Oil & Gas |
| M&C Saachi |
| Densitron Technologies |
| Eden Research |
| Global Energy Developments |
| Orogen Gold |
| Sopheon |
| IQE |
| Share |
| SOCO International |
| Venture Life Group |
| Witan Pacific Investment Trust |
| Thursday, June 11 |
| Dignity |
| REA Holdings |
| Graphite Enterprise Trust |
| Ascent Resources |
| Camkids Group |
| Black Sea Property |
| Source BioScience |
| e-Therapeutics |
| Martin Currie Global Portfolio Trust |
| Synergy Health |
| MX Oil |
| Serabi Gold |
| SciSys |
| Verona Pharma |
| Friday, June 12 |
| Baker Steel Resources |
| Tex Holdings |
| Ted Baker |
| Tekcapital |
| Monday, June 15 |
| Kefi Minerals |
| President Energy |
| Netdimensions |
| P2P Global Investments |
| Tuesday, June 16 |
| Plant Health Care |
| Servoca |
| Cyan Holdings |
| StratMin Global Resources |
| Inspired Energy |
| Huntsworth |
| HSS Hire Group |
| Premier Farnell |
| NMC Health |
| Christie Group |
| Whitbread |
| UK Commercial Property |
| Copyright 2015 Alliance News Limited. All Rights Reserved. |
12 Jan 2015 11:55
Verona Pharma doses first volunteers in 'RPL554' asthma trial
Verona Pharma said the first group of volunteers have been dosed with its new nebulised formulation of its RPL554 product as part of a Phase I/II clinical trial, which analysts said was a significant step. The AIM company said the study's main objective was to confirm the safety, tolerability and br
Read more